Sunday, August 21, 2016

Pfizer is reportedly close to spending $14 billion on cancer drugmaker Medivation (MDVN, PFE)

… on the market to treat prostate cancer. And its big appeal comes … to repair DNA so that tumors can't survive.
Here … is used to treat late-stage prostate cancer. It was originally approved by … of prostate, breast and liver cancers.
Medivation also has two other cancer drugs …

No comments:

Post a Comment